Role of carbohydrate moiety of bleomycin-A2 in caspase-3 activation and internucleosomal chromatin fragmentation in apoptosis of laryngeal carcinoma cells

Cell Biology International

Volumn 32, Issue 2, 2008, Pages 171-177

  Brahim, Souhir ^a   Abid, Kaouthar ^a   Kenani, Abderraouf ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Apoptosis; Bleomycin A2; Caspase 3; Deglycobleomycin A2; DNA ladder; HEp 2 cells line

Indexed keywords

BLEOMYCIN A2; CARBOHYDRATE; CASPASE 3; GENOMIC DNA;

APOPTOSIS; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CARBOHYDRATE ANALYSIS; CARCINOMA CELL; CELL STRUCTURE; CHROMATIN; CONCENTRATION RESPONSE; DEGLYCOSYLATION; DRUG CYTOTOXICITY; ENZYME ACTIVATION; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; LARYNX CARCINOMA; NUCLEOSOME; OBSERVATIONAL STUDY; REVIEW;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLEOMYCIN; CASPASE 3; CELL LINE, TUMOR; CELL SHAPE; CHROMATIN; DNA FRAGMENTATION; ENZYME ACTIVATION; GLYCOSYLATION; HUMANS; LARYNGEAL NEOPLASMS; NUCLEOSOMES; POLYSACCHARIDES;

EID: 39749103507     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.08.032     Document Type: Review

References (40)

1. Adriana M., Agnieszka B., Anna B.Z., Katarzyna P., Grażyna M., and Ewa S. Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8+ cells. Acta Biochim Pol 53 (2006) 531-538
2. Beni B.W., Martin S., Fernando E., and Douglas R.G. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 274 (1999) 30651-30656
3. Bettaieb A., and Laurent G. Apoptose induite par les agents antitumoraux. Hématologie 3 (1997) 146-154
4. Burger R.M. Cleavage of nucleic acids by bleomycin. Chem Rev 98 (1989) 1153-1169
5. 2 and bleomycin-induced oxidative stress in L6C5 rat myoblasts. Free Radic Biol Med 35 (2003) 1355-1364
6. Chang B.D., Swift M.E., Shen M., Fang J., Broude E.V., and Roninson I.B. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci 99 (2001) 389-394
7. Chen J., and Stubbe J. Bleomycins: towards better therapeutics. Nature 5 (2005) 102-112
8. Chien M., Grollman A.P., and Horwitz S.B. Bleomycin-DNA interactions: fluorescence and proton magnetic resonance studies. Biochemistry 16 (1977) 3641
9. Debatin K.M. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett 112-113 (2000) 41-48
10. Fadok V.A., Bratton L.D., Frasch S.C., Warner M.L., and Henson P.M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 5 (1998) 551-562
11. Fulda S., and Debatin K.M. Signaling through death receptors in cancer therapy. Curr Opin Pharmacol 4 (2004) 327-332
12. Higuchi Y. Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 8 (2004) 455-464
13. Hoffmann P.R., deCathlineau A.M., Ogden C.A., Leverrier Y., Bratton L.D., Daleke L.D., et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155 (2001) 649-659
14. Hong J.S., Ko H.H., Han E.S., and Lee C.S. Inhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol. Biochem Pharmacol 66 (2003) 1297-1306
15. Hu W., and Kavanagh J.J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4 (2003) 721-729
16. Ichikawa T., Nakano I., and Hirokawa I. Bleomycin treatment of the tumors of penis and scrotum. J Urol 102 (1969) 699-707
17. Kanduc D., Mittelman A., Serpico R., Sinigaglia E., Sinha A.A., Natale C., et al. Cell death: apoptosis versus necrosis. Int J Oncol 21 (2002) 165-170
18. Kenani A., Lohez M., Houssin R., Helbecque N., Bernier J.L., Lemay P., et al. Chelating, DNA-binding and DNA-cleaving properties of a synthetic model for bleomycin. Anti-cancer Drug Des 2 (1987) 47-59
19. 2. Carbohydr Res 177 (1988) 81-89
20. Kerr J.F.R., Winterford C.M., Biol A.D.A., and Harmon B.V. Apoptosis: its significance in cancer and cancer therapy. Cancer 73 (1994) 2013-2026
21. Kumiko S., Shigenobu T., and William C.E. CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis. J Biol Chem 276 (2001) 45427-45432
22. Lehmann T.E., LiJ M., Rosen M.E., and Lawrence Q.J. NMR studies of the paramagnetic complex Fe(II)-bleomycin. Biochemistry 36 (1997) 28107-28167
23. Los M., Burek C.J., Stroh C., Benedyk K., Hug H., and Mackiewicz A. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov Today 8 (2003) 67-77
24. Martin S.J., and Green D.R. Apoptosis as a goal of cancer therapy. Curr Opin Oncol 6 (1994) 616-621
25. Nicholson D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407 (2000) 810-816
26. Pelicano H., Carney D., and Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7 (2004) 97-110
27. Petak I., and Houghton J.A. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res 7 (2001) 95-106
28. Povirk L.M., and Austin M.J.F. Genotoxicity of bleomycin. Mutat Res 257 (1991) 127-143
29. Ramotar D., and Wang H. Protective mechanisms against the antitumor agent bleomycin: lessons from Saccaromyces cerevisiae. Curr Genet 43 (2003) 213-224
30. Sam J.W., and Peisach P. EPR spectroscopic investigation of lability of oxygen in activated bleomycin: implications for the mechanism of bleomycin-mediated DNA degradation. Biochemistry 32 (1993) 1488-1491
31. Sam J.W., Takahashi S., Lippai I., Peisach J., and Rousseau D.L. Sequence-specific changes in the Metal site of Ferric bleomycin induced by the binding of DNA. J Biol Chem 273 (1998) 16090-16097
32. Solovyan V.T. Characterization of apoptotic pathway associated with caspase-independent excision of DNA loop domains. Exp Cell Res 313 (2007) 1347-1360
33. Tai K.W., Chou M.Y., Hu C.C., Yang J.J., and Chang Y.C. Induction of apoptosis in KB cells by pingyangmycin. Oral Oncol 36 (2000) 242-247
34. Terasima T., and Umezawa H. Lethal effect of bleomycin on cultured mammalian cells. J Antibiot 23 (1970) 300-304
35. Tounekti O., Belehradek J.J., and Mir L.M. La bléomycine est un agent anticancéreux capable de mimer l'apoptose. Bull Cancer 81 (1994) 1043-1049
36. Tounekti O., Kenani A., Foray N., Orlowski S., and Mir L.M. The ratio of single to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer 84 (2001) 1272-1279
37. Umezawa H., Maeda K., Takenchi T., and Okama Y. J Antibiot A19 (1966) 200-209
38. Vernole P., Tedeschi B., Caporossi D., Maccarrone M., Melino G., and Annicchirico P. Mutagenesis 13 (1998) 209-215
39. Widalk P. The DFF40/CAD endonuclease and its role in apoptosis. Acta Biochim Pol 47 (2000) 1037-1044
40. Yoshida A., Pommier Y., and Ueda T. Endonuclease activation and chromosomal DNA fragmentation during apoptosis in leukemia cells. Int J Hematol 84 (2006) 31-37